Insider filing · RGEN
Olivier Loeillot
Chief Executive Officer
profile →
Repligen Corporation
RGEN · Healthcare · 17 filings in 24 months
ticker →
Olivier Loeillot sold $977K of Repligen (RGEN)
Executed Aug 20, disclosed Aug 21, 1 day later.
Value, as filed
$977K
5,426 sh × $180.00
Executed
Aug 20
the trade date, as filed
Disclosed
Aug 21
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
OLOlivier Loeillot (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Repligen Corporation (RGEN). The largest single filing was $1.2M of RGEN (7,041 sh × $170.00, as filed), executed Nov 25 2025.
The name
RGENHealthcare · Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Olivier Loeillot in RGEN
RGENSALE
Repligen Corporation
$977K5,426 sh × $180.00
Exec Sep 21
Filed Sep 22 · 4:07 PM ET RGENSALE Repligen Corporation $504K
3,035 sh × $165.90
Exec Sep 4
Filed Sep 8 · 4:13 PM ET RGENSALE Repligen Corporation $536K
3,832 sh × $140.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET RGENSALE Repligen Corporation $1.2M
7,041 sh × $170.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET